Antibody based Cancer Therapies



May 30, 2023

  • Share
  • Therapeutic antibodies are monoclonal antibodies developed to attack specific cells or proteins for the treatment of a wide variety of diseases, including immune disorders, cancers, and infections. Currently, there are 65 monoclonal antibodies (mAbs) approved by FDA for clinical use and more than 350 are being evaluated in clinical trials. Therapeutic antibody development has entered a rapid growth phase in demand of therapeutic market, with recognition of their potential and unprecedented success.

    Drug DiscoveryImmunology

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.